342 related articles for article (PubMed ID: 33738519)
1. Image quality and lesion detectability in low-dose pediatric
Zhao YM; Li YH; Chen T; Zhang WG; Wang LH; Feng J; Li C; Zhang X; Fan W; Hu YY
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3378-3385. PubMed ID: 33738519
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [
Chen W; Liu L; Li Y; Li S; Li Z; Zhang W; Zhang X; Wu R; Hu D; Sun H; Zhou Y; Fan W; Zhao Y; Zhang Y; Hu Y
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4145-4155. PubMed ID: 35788704
[TBL] [Abstract][Full Text] [Related]
3. The image quality, lesion detectability, and acquisition time of
Zhang YQ; Hu PC; Wu RZ; Gu YS; Chen SG; Yu HJ; Wang XQ; Song J; Shi HC
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2507-2515. PubMed ID: 32424483
[TBL] [Abstract][Full Text] [Related]
4. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.
Tan H; Sui X; Yin H; Yu H; Gu Y; Chen S; Hu P; Mao W; Shi H
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1966-1975. PubMed ID: 33244618
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of short acquisition time using
Li M; Cui X; Yue H; Ma C; Li K; Chai L; Ge M; Li H; Ng YL; Zhou Y; Shi J; Duan Y; Cheng Z
EJNMMI Res; 2024 Feb; 14(1):21. PubMed ID: 38409511
[TBL] [Abstract][Full Text] [Related]
6. Defining optimal tracer activities in pediatric oncologic whole-body
Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF; Schäfer JF
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
[TBL] [Abstract][Full Text] [Related]
7. Investigating Low-Dose Image Quality in Whole-Body Pediatric
Schmall JP; Surti S; Otero HJ; Servaes S; Karp JS; States LJ
J Nucl Med; 2021 Jan; 62(1):123-130. PubMed ID: 32482791
[TBL] [Abstract][Full Text] [Related]
8. Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.
Alves VPV; Brady S; Ata NA; Li Y; MacLean J; Zhang B; Sharp SE; Trout AT
AJR Am J Roentgenol; 2022 Dec; 219(6):952-961. PubMed ID: 35731102
[No Abstract] [Full Text] [Related]
9. Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience.
Tan H; Cai D; Sui X; Qi C; Mao W; Zhang Y; Liu G; Yu H; Chen S; Hu P; Gu J; Shi H
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1002-1011. PubMed ID: 34462790
[TBL] [Abstract][Full Text] [Related]
10. Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.
Tan H; Mao W; Cao Y; Cai D; Sui X; Qi C; Yu H; Zhang Y; Shi H
Nucl Med Commun; 2022 Aug; 43(8):928-936. PubMed ID: 35634804
[TBL] [Abstract][Full Text] [Related]
11. Head-to-head intra-individual comparison of total-body 2-[
Chen X; Hu P; Yu H; Tan H; He Y; Cao S; Zhou Y; Shi H
Eur Radiol; 2023 Nov; 33(11):7890-7898. PubMed ID: 37338551
[TBL] [Abstract][Full Text] [Related]
12. Reduced count pediatric whole-body
Alves VPV; Ata NA; MacLean J; Sharp SE; Li Y; Brady S; Trout AT
Pediatr Radiol; 2024 Jan; 54(1):170-180. PubMed ID: 37962603
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of image metrics for reduced and standard dose pediatric
Zucchetta P; Branchini M; Zorz A; Bodanza V; Cecchin D; Paiusco M; Bui F
Br J Radiol; 2019 Mar; 92(1095):20180438. PubMed ID: 30673306
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of acquisitions using total-body PET/CT with a half-dose [
Chen Z; Wang Y; Yang X; Li L; Huo Y; Yu X; Xiao X; Zhang C; Chen Y; Zhao H; Zhou Y; Huang G; Liu J; Chen R
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3961-3969. PubMed ID: 37535107
[TBL] [Abstract][Full Text] [Related]
15. Ultralow-dose [
Tan H; Qi C; Cao Y; Cai D; Mao W; Yu H; Sui X; Liu G; Shi H
Eur Radiol; 2023 Jul; 33(7):5017-5027. PubMed ID: 36688971
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low
Hu Y; Liu G; Yu H; Wang Y; Li C; Tan H; Chen S; Gu J; Shi H
J Nucl Med; 2022 Jun; 63(6):959-965. PubMed ID: 34593593
[TBL] [Abstract][Full Text] [Related]
17. Simulation of Tracer Dose Reduction in
Seith F; Schmidt H; Kunz J; Küstner T; Gatidis S; Nikolaou K; la Fougère C; Schwenzer N
J Nucl Med; 2017 Oct; 58(10):1699-1705. PubMed ID: 28360205
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of optimal acquisition duration or injected activity for pediatric 18F-FDG PET/CT.
Alessio AM; Sammer M; Phillips GS; Manchanda V; Mohr BC; Parisi MT
J Nucl Med; 2011 Jul; 52(7):1028-34. PubMed ID: 21680684
[TBL] [Abstract][Full Text] [Related]
19. Total-body
Hu P; Zhang Y; Yu H; Chen S; Tan H; Qi C; Dong Y; Wang Y; Deng Z; Shi H
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2384-2394. PubMed ID: 33866409
[TBL] [Abstract][Full Text] [Related]
20. Image Quality and Activity Optimization in Oncologic
van Sluis J; Boellaard R; Dierckx RAJO; Stormezand GN; Glaudemans AWJM; Noordzij W
J Nucl Med; 2020 May; 61(5):764-771. PubMed ID: 31628214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]